Clean air trial hopes to ease breathing for rare lung disease patients

NCT ID NCT07417267

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether using HEPA air purifiers at home can reduce respiratory symptoms and improve lung function in children and adults with Cystic Fibrosis (CF) or Primary Ciliary Dyskinesia (PCD). Participants will have two purifiers installed in their home and will undergo lung function tests and symptom checks over several months. The goal is to see if cleaner indoor air makes a real difference in their daily breathing and overall health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical School, University of Cyprus

    Nicosia, Aglantzia, 2029, Cyprus

More trials for these conditions

Other studies related to the condition(s) this trial covers.